Danaher Announces New Dental Company To Be Named Envista Holdings Corporation

WASHINGTON, June 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Envista Holdings Corporation (“Envista” or the “Company”) will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019.  Envista will be comprised of three operating companies within... Read more

Promega 2019 Corporate Responsibility Report Highlights Commitments to Environmental Sustainability, Employee Well-Being and Community Support

Madison, WI USA. (June 26, 2019) Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year. The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint. “We not... Read more

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration Studies aim to elucidate infertility genetics for development of noninvasive test to support decision making and improved outcomes for women pursuing fertility treatment CARLSBAD, Calif., June 19, 2019 /PRNewswire/ — Thermo Fisher Scientific announced today that it has entered into a global research collaboration... Read more

X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration

June 19, 2019 First plan apochromat objectives in the world to achieve a numerical aperture of 1.5*1 were launched concurrently It is difficult to improve one area of an objective lens, such as numerical aperture, without tradeoffs in another area, like chromatic aberration correction. However, X Line objectives overcome the common tradeoffs by simultaneously improving optical... Read more

Danaher Schedules Second Quarter 2019 Earnings Conference Call

WASHINGTON, June 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

QIAGEN to deliver genomic insights for Japan’s new molecular oncology clinical research and precision medicine initiative

Hilden, Germany, and Tokyo, Japan, June 18, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QIAGEN Clinical Insight (QCI) offering was selected by the National Cancer Center of Japan, as part of the Japan’s Ministry of Health, Labour and Welfare’s precision medicine program, for the analysis, interpretation and reporting of molecular... Read more

Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Test

June 18, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera Inc., the leader in silicon-based nanopore diagnostics, announced today that the company has received a $982,593 contract from Intelligence Advanced Research Projects Activity (IARPA), part of the Office of the Director of National Intelligence that invests in research and innovative technologies to strengthen... Read more

Thermo Fisher Scientific Launches Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging

Thermo Fisher Scientific Launches Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging Featuring advanced time saving technology and intuitive user interface, designed to accelerate science CARLSBAD, Calif., June 17, 2019 /PRNewswire/ — For biological researchers requiring high-quality images from their samples without over-investing time and resources, a new, easy-to-use imaging platform... Read more

QIAGEN launches novel NGS panel for rare and inherited diseases with advanced bioinformatics for complete Sample to Insight solution

Hilden, Germany, and Germantown, Maryland, June 14, 2019 – QIAGEN today announced the launch of a novel Sample to Insight solution for translational and clinical research into genetic drivers of rare and inherited diseases. The new QIAseq Expanded Carrier Screening Panel provides identification of targets, genes and other regions of interest responsible for more than 200... Read more